Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Return on Invested Capital: 2011-2025

Historic Return on Invested Capital for Lifecore Biomedical (LFCR) over the last 6 years, with Feb 2025 value amounting to -0.16%.

  • Lifecore Biomedical's Return on Invested Capital was N/A to -0.16% in Q1 2025 from the same period last year, while for Feb 2025 it was -0.16%, marking a year-over-year change of. This contributed to the annual value of -0.08% for FY2024, which is N/A change from last year.
  • As of Q1 2025, Lifecore Biomedical's Return on Invested Capital stood at -0.16%, which was down 64.11% from -0.10% recorded in Q3 2024.
  • In the past 5 years, Lifecore Biomedical's Return on Invested Capital ranged from a high of -0.00% in Q4 2021 and a low of -0.16% during Q1 2025.
  • In the last 3 years, Lifecore Biomedical's Return on Invested Capital had a median value of -0.11% in 2023 and averaged -0.11%.
  • Per our database at Business Quant, Lifecore Biomedical's Return on Invested Capital climbed by 6bps in 2021 and then dropped by 9bps in 2023.
  • Lifecore Biomedical's Return on Invested Capital (Quarterly) stood at -0.00% in 2021, then fell by 5bps to -0.05% in 2022, then declined by 9bps to -0.12% in 2023, then reached -0.10% in 2024, then reached -0.16% in 2025.
  • Its Return on Invested Capital was -0.16% in Q1 2025, compared to -0.10% in Q3 2024 and -0.07% in Q2 2024.